Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

96.67 +3.81 (+4.10%)
Streaming Delayed Price Updated: 3:47 PM EST, Nov 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,979,032
Open 94.11
Bid (Size) 96.66 (100)
Ask (Size) 96.67 (400)
Prev. Close 92.86
Today's Range 92.11 - 97.66
52wk Range 73.31 - 105.07
Shares Outstanding 2,531,374,696
Dividend Yield 3.35%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Which S&P500 stocks are moving on Tuesday? ↗
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday. 
Via Chartmill
News headline image
Market Movers in Motion: Merck & Co. and Amer Sports Chart Volatile Courses
The financial markets are a constant theater of dynamic shifts, and in recent months, two distinct players – pharmaceutical giant Merck & Co. and global sporting goods powerhouse Amer Sports – have... 
Via MarketMinute
Topics Economy Initial Public Offering Intellectual Property

Performance

YTD
-2.5%
-2.5%
1 Month
+12.0%
+12.0%
3 Month
+14.8%
+14.8%
6 Month
+25.2%
+25.2%
1 Year
+0.1%
+0.1%

More News

Read More
News headline image
Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday? ↗
Via Benzinga
Cidara Therapeutics Stock Rockets Over 700% This Year — Then Wall Street Turns Neutral On Merck Takeover ↗
Via Stocktwits
News headline image
Which S&P500 stocks have an unusual volume on Tuesday? ↗
Via Chartmill
News headline image
Merck's Winrevair Success Extends Beyond Pulmonary Hypertension, Showing Promise In Complex Heart Condition ↗
Via Benzinga
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Merck Announces First-Quarter 2026 Dividend
From Merck & Co., Inc.
Via Business Wire
News headline image
Merck Jumps On A Surprise Win; Why It Still Has A Long Road To Go ↗
Via Investor's Business Daily
Topics Government
News headline image
Top S&P500 movers in Tuesday's pre-market session ↗
Via Chartmill
News headline image
Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year ↗
Via Investor's Business Daily
News headline image
Merck’s WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With Combined Post- and Precapillary Pulmonary Hypertension (CpcPH) due to Heart Failure With Preserved Ejection Fraction (HFpEF)
From Merck & Co., Inc.
Via Business Wire
News headline image
Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗
Via Benzinga
Topics ETFs
News headline image
Top 2 Health Care Stocks That May Fall Off A Cliff This Month ↗
Via Benzinga
News headline image
MERCK & CO. INC. (NYSE:MRK): A Value Investment with Strong Fundamentals ↗
Via Chartmill
News headline image
Market Grapples with Valuation Fears Amidst Accelerating Sector Rotation
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
These 2 Dividend ETFs Are a Retiree's Best Friend ↗
Via The Motley Fool
Topics Artificial Intelligence Bonds ETFs
News headline image
AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines
Via TokenRing AI
Topics Artificial Intelligence Economy Product Recall
News headline image
AI and Digital Twins Ignite a New Era of Accelerated Drug Discovery and Development
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal ↗
Via Investor's Business Daily
News headline image
Merck Makes Big Bet On Flu Protection With Cidara Buyout ↗
Via Benzinga
News headline image
Merck To Buy Cidara In $9.2B Deal To Strengthen Antiviral Portfolio ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
From Merck & Co., Inc.
Via Business Wire

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 96.67
When was Merck & Co last traded?
The last trade of Merck & Co was at 11/18/25 03:47 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 244.70B
How many shares of Merck & Co are outstanding?
Merck & Co has 245B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.